Drug Trial Radar · NCT05493800
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT
Last checked: Nov 19, 2026Latest source record: May 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Feb 1, 2022
Primary completion
Jun 30, 2024
Study completion Dec 30, 2024
Sponsor
- Lead sponsor
- MitoImmune TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Aug 9, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the efficacy and safety for the prevention of oral mucositis and PK of MIT-001 for lymphoma or multiple myeloma patients receiving conditioning chemotherapy for autologous hematopoietic stem cell transplantation(auto-HSCT).
Conditions
- Oral Mucositis
- Lymphoma
- Multiple Myeloma
- Hematologic Cancer
Interventions
MIT-001Drug
Corresponding dose of MIT-001 IV injection during 0.5\~1hr
normal salineDrug
normal saline IV injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of Severe Oral Mucositis(SOM).Time frame: up to 14 days after the end of therapy( or discharge if hospitalization extension is necessary)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Seoul ST. Mary's Hospital
Seoul, South Korea
Yeouido ST. Mary's Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.